Galera Therapeutics

Biotech

Galera shares rise over 100% as phase 3 flop deemed an error

Galera says an error made by a CRO was discovered, and the radiotherapy complication drug did in fact work in a phase 3 study.
Annalee Armstrong Dec 14, 2021 3:30pm

Galera shares slide as radiotherapy complication drug fails

Oct 19, 2021 11:53am

Galera reels in $150M to test radiation side effect med in phase 3

Sep 19, 2018 11:10am

Poised for phase 3, Galera's GC4419 wards off radiation side effects

Aug 20, 2018 5:00am